A summary of lymphoma immune checkpoint inhibitor data at EHA 2017
Monoclonal antibodies and checkpoint inhibitors for multiple myeloma
Phase I trial results for nivolumab and pembrolizumab in lymphoma and multiple myeloma
How immunomodulatory drugs have reinforced the value of the immune system in multiple myeloma
Jesús San Miguel
An update on immunotherapy for multiple myeloma in 2016
Ignacio Melero Bermejo et al.